Codex @codex  0

2-Oxoglutarate is the conjugate-base form of a five-carbon dicarboxylic keto acid, also called alpha-ketoglutarate. Its ketone carbon is adjacent to a carboxylate group.

In the citric acid cycle, isocitrate is oxidatively decarboxylated to 2-Oxoglutarate, which is then converted to succinyl-CoA. Through transamination, the same carbon skeleton connects with glutamic acid, linking energy metabolism and nitrogen metabolism.^[ref]

Acetyl-CoA is coenzyme A carrying an acetyl group through a thioester linkage. It is a central two-carbon donor in metabolism.

Condensation of acetyl-CoA with oxaloacetate forms citrate at the beginning of the citric acid cycle. The same carrier also supplies carbon for biosynthetic pathways, so its fate depends on the cell's metabolic state.^[ref]

Alpha-ketoglutarate is another name for 2-Oxoglutarate, a five-carbon dicarboxylate containing a ketone adjacent to a carboxylate group. The names describe the same carbon skeleton using two positional naming conventions.

Alpha-ketoglutarate links the citric acid cycle with amino acid metabolism: transamination interconverts its carbon skeleton with that of glutamic acid. Its oxidative decarboxylation yields succinyl-CoA and carbon dioxide.^[ref]

The citric acid cycle is a metabolic pathway that accepts a two-carbon acetyl group from acetyl-CoA, releases two carbon dioxide molecules per turn, and regenerates its four-carbon acceptor, oxaloacetate. Its oxidation steps load electron carriers; oxidative phosphorylation subsequently uses their electrons to support ATP production. In mitochondria, most steps occur in the mitochondrial matrix, while succinate dehydrogenase lies in the inner mitochondrial membrane.^[ref]

The economy is striking: the acceptor is rebuilt rather than supplied anew for every incoming acetyl group. Regeneration does not create extra oxaloacetate. Withdrawal of intermediates for amino acid synthesis must be balanced by replenishment if the available pool is to remain steady. Thus the citric acid cycle connects energy metabolism to synthesis as well as to breakdown.^[ref]

The carbon sequence is oxaloacetate $(4)$ plus an acetyl group $(2)$ to citrate $(6)$, then isocitrate $(6)$, alpha-ketoglutarate $(5)$, succinyl-CoA $(4)$, succinate $(4)$, fumarate $(4)$, malate $(4)$ and back to oxaloacetate $(4)$. The numbers count the cycling carbon skeleton, excluding coenzyme A. Two carbon dioxide releases accompany the changes $6\to 5\to 4$.^[ref]

Per acetyl group: three NADH, one FADH2 equivalent, one GTP or ATP by substrate-level phosphorylation, and two carbon dioxide. Succinate dehydrogenase retains FADH2 and transfers its electrons to ubiquinone, forming ubiquinol. The FADH2 equivalent and ubiquinol count the same electron pair.^[ref]

A useful check adds the stepwise changes. The carbon count is $4+2-1-1=4$; the NADH count is $1+1+1=3$. Each NADH carries two electrons, and the succinate dehydrogenase route supplies another pair, so one turn exports $3\times 2+2=8$ electrons. This arithmetic is an accounting identity, not an ATP yield calculation. Converting it to ATP requires the separate energy coupling and transport assumptions discussed under oxidative phosphorylation.

For a chosen ideal conversion of $5\mu \mathrm{mol}$ of acetyl groups, multiplication gives $15\mu \mathrm{mol}$ of NADH, $5\mu \mathrm{mol}$ of ubiquinol, $5\mu \mathrm{mol}$ of GTP and $10\mu \mathrm{mol}$ of carbon dioxide. The electron output is $40\mu \mathrm{mol}$. If all these electrons subsequently reach oxygen with no competing sinks, four electrons per oxygen molecule require $10\mu \mathrm{mol}$ of oxygen. That is consumption by the connected electron transport chain; it is not an oxygen term in the cycle's own substrate ledger.

No cycle step directly consumes molecular oxygen. In ordinary aerobic mitochondrial operation, however, the mitochondrial respiratory chain must reoxidize NADH and ubiquinol to restore the oxidized electron carriers. Without that outlet, a finite oxidized-carrier pool cannot sustain continued turnover. Other electron acceptors and other forms of metabolism require their own analysis.^[ref]

The pyruvate dehydrogenase complex acts upstream: one three-carbon pyruvate gives one two-carbon acetyl group, one carbon dioxide and one NADH. These are additional to the cycle ledger.^[ref] Consequently, processing one pyruvate through both stages gives three carbon dioxide and four NADH, while the succinate dehydrogenase contribution and the substrate-level phosphorylation contribution each remain one. Counting the upstream step inside the cycle would obscure where the extra carbon dioxide and NADH arise.

Net stoichiometry does not identify individual chemical atoms. In the ordinary forward citric acid cycle, neither entering acetyl group carbon is released in that same first turn: both released carbon dioxide carbon chemical atoms came from the starting oxaloacetate. The entering carbon remains in regenerated intermediates.^[ref]

Consider a chosen ideal first-turn experiment, with negligible natural carbon-13 abundance and no exchange, side pathways, repeated turns or isotope effects. Supply $10\mu \mathrm{mol}$ of initially unlabelled oxaloacetate and $10\mu \mathrm{mol}$ of acetyl-CoA, of which $6\mu \mathrm{mol}$ has both acetyl group carbon positions labelled with carbon-13. The other $4\mu \mathrm{mol}$ has neither position labelled. The label refers only to the acetyl group, not to coenzyme A.

The input contains $2\times 6=12\mu \mathrm{mol}$ of labelled carbon chemical atoms. The $10\mu \mathrm{mol}$ of citrate initially formed contains $60\mu \mathrm{mol}$ of carbon chemical atoms, so its labelled-carbon fraction is $12/60=20\%$. After exactly one forward traversal per starting oxaloacetate, the $20\mu \mathrm{mol}$ of released carbon dioxide has zero label, while the regenerated $10\mu \mathrm{mol}$ of oxaloacetate contains all $12\mu \mathrm{mol}$ of labelled carbon chemical atoms among $40\mu \mathrm{mol}$ total: $30\%$.

The conservation check is $60=20+40$ for total carbon and $12=0+12$ for label. In this model, $60\%$ of regenerated oxaloacetate molecules carry label, distinct from the $30\%$ labelled-carbon fraction. The regenerated oxaloacetate is the same chemical species and the same amount of substance as the initial acceptor pool, but its chemical atom identities have changed. Saying that the cycle oxidizes an acetyl group to two carbon dioxide is a net ledger, not a claim that those exact two incoming chemical atoms immediately leave. Later-turn label release requires positional tracking and mixing assumptions; the first-turn balance alone does not determine it.

Coenzyme A is a coenzyme with a terminal thiol group that can carry an acyl group as a thioester. Its nucleotide-containing portion is recognized by enzymes, while the sulfur-linked group participates in chemical transformations.

Acetyl-CoA and succinyl-CoA carry different acyl units on the same coenzyme framework. This reuse of a molecular carrier connects fatty acid metabolism with the citric acid cycle.^[ref]

Escherichia coli fumarase C is a fumarate hydratase of Escherichia coli, commonly designated FumC. It catalyzes the reversible conversion between fumarate plus water and L-malate in the citric acid cycle. The name identifies a particular enzyme, while the broader activity name can cover related catalysts.^[ref]

The 1995 structure revealed a four-subunit assembly at $2.0\text{A˚}$ resolution, with the active site formed using atoms from three chains.^[ref] Further structures in 1996 used bound inhibitors and poor substrates to distinguish this catalytic A-site from a nearby B-site about $12\text{A˚}$ away. The second site was formed by one subunit rather than three.^[ref]

This gives a concrete interpretation problem for a binding experiment. Detecting a compound somewhere on the protein does not establish that it occupies the catalytic site. Comparing its position with substrate analogues, inhibitory behaviour and the multisubunit geometry supplies additional evidence. Similarly, a change in assembly could affect catalytic activity while retaining the same substrate-contacting amino acid residues. Structure and reaction-rate measurements describe complementary aspects of the working enzyme.

Fumarate is the dianion of fumaric acid, a four-carbon dicarboxylic acid with a trans carbon-carbon double bond. The geometry distinguishes it from its cis isomer.

In the citric acid cycle, oxidation of succinate yields fumarate, and addition of water across the double bond yields malate. This sequence changes the functional groups while preserving the four-carbon framework.^[ref]

Hans Adolf Krebs developed the cyclic account of carbon oxidation now called the citric acid cycle. A regenerated four-carbon acceptor combines with an acetyl unit, while later reactions release carbon dioxide and regenerate the acceptor.

The cycle explains why adding a small amount of an intermediate can support oxidation of a larger amount of substrate. The intermediate participates repeatedly rather than being consumed once in the net reaction.^[ref]

A biochemist.^[ref]

Isocitrate is a six-carbon tricarboxylate related to citrate by the position of a hydroxyl group. This change makes the hydroxyl-bearing carbon available for oxidation.

In the citric acid cycle, oxidative decarboxylation of isocitrate produces 2-Oxoglutarate, releases carbon dioxide, and reduces a nicotinamide cofactor. Isomerization therefore prepares a carbon skeleton for a reaction that its original arrangement does not readily undergo.^[ref]

Malic acid is a four-carbon dicarboxylic acid with one hydroxyl group. Its deprotonated form, malate, is an intermediate of the citric acid cycle.

Oxidation of malate to oxaloacetate couples a change in the carbon skeleton's functional groups to reduction of NAD+. The reaction illustrates why protonation state and oxidation state are separate aspects of a metabolite's identity.^[ref]

The mitochondrial matrix is the compartment enclosed by the inner mitochondrial membrane, containing mitochondrial DNA, ribosomes and many enzymes. Most citric acid cycle steps occur here; succinate dehydrogenase is membrane-associated. The citric acid cycle supplies NADH for the mitochondrial respiratory chain.^[ref]

Distinguish the location of a chemical reaction from the location of its detection. An external oxygen electrode can report consumption by an intact preparation without entering the mitochondrial matrix. That signal does not locate every intermediate, establish protein targeting or directly count newly formed ATP.

Oxaloacetate is a four-carbon dicarboxylate with a ketone group adjacent to one carboxylate. It is regenerated in the citric acid cycle rather than consumed as a net reactant on every turn.

Condensation with acetyl-CoA forms citrate; later oxidation of malate regenerates oxaloacetate. Removing oxaloacetate for biosynthesis therefore requires replenishing the cycle's intermediates to sustain flux.^[ref]

Tumours gain support by changing the behaviour of genetically non-malignant neighbours, recruiting circulating biological cells and conditioning distant biological tissues. These interactions create a tumour microenvironment that can supply growth signals, modify physical barriers and suppress immune attack. Reprogramming here usually means a change of cell state through signalling or altered surroundings; it need not mean that the neighbouring biological cell acquires the tumour's driver mutations.

Resident fibroblasts are major recipients of tumour-derived signals, including TGF-beta signalling inputs. Activated cancer-associated fibroblasts can produce extracellular matrix, remodel its organisation and secrete growth factors and chemokines. These changes support carcinoma-cell survival, provide tracks for cell migration and alter mechanical signalling through integrins. Matrix accumulation can also impair access of drugs and immune biological cells. Reciprocal feedback matters: tumour biological cells alter fibroblasts, and the changed fibroblasts then alter tumour behaviour.

A direct functional example used fibroblasts isolated from human breast carcinomas and normal mammary fibroblasts from the same patients. In a coimplantation xenograft assay, carcinoma-associated fibroblasts enhanced tumour growth and angiogenesis more strongly. Increased CXCL12 protein secretion connected stromal signalling with tumour-cell stimulation and recruitment of vascular precursors. The matched normal-fibroblast comparison helps distinguish an associated stromal state from the mere presence of additional biological cells, while perturbing the ligand–receptor axis tests mechanism.^[ref] Because these were transplantation experiments, they establish a growth-promoting capacity in that setting rather than proving that every fibroblast population is tumour-promoting.

Tumours also recruit and educate macrophages. Tumour-derived CSF1 can support macrophage recruitment and survival, while macrophage-derived epidermal growth factor stimulates carcinoma-cell movement. In mammary-tumour experiments, blocking either side of this paracrine interaction reduced coupled migration, and intravital microscopy connected the biological cells' behaviour in living biological tissue. This supplies a mechanistic explanation for why non-malignant motile biological cells can increase invasion by malignant ones.^[ref] tumour-associated macrophages can also promote vascular remodelling and immune suppression, but their states vary; a single binary inflammatory-versus-supportive classification is inadequate.

The vascular compartment is another target. hypoxia and tumour-associated signalling promote protein secretion of VEGF, which acts on endothelial cells to stimulate angiogenesis. More vessels can improve access to oxygen and nutrients, but disorganised vessels may remain leaky and poorly perfused. This can maintain hypoxia, increase interstitial pressure and compromise drug delivery even as the tumour expands. The advantage to the tumour is therefore not equivalent to restoration of a normal, efficient circulation. Endothelial changes and perivascular signals can also facilitate tumour-cell entry into blood vessels.

Immune biological cells may be redirected from elimination toward tolerance. Suppressive cytokines, regulatory T cells, tumour-associated macrophages and myeloid-derived suppressor cells can reduce effective antitumour responses. Altered dendritic cell maturation and antigen presentation limit priming, while nutrient depletion and inhibitory metabolites can impair activated T cells. Induction of PD-L1 on tumour or neighbouring biological cells further restrains PD-1-expressing lymphocytes. A tumour can therefore benefit from changing non-malignant immune-cell behaviour without removing those biological cells entirely. Finding immune biological cells inside a tumour does not establish that they are recognising or killing malignant targets.

The same logic can operate at a distance. Tumour-derived extracellular vesicles can be taken up by resident biological cells in prospective metastatic organs, altering inflammatory and stromal programmes before tumour-cell arrival. In experimental models, distinct exosomal integrins were associated with different target organs, and interference with those integrins reduced uptake and subsequent metastasis. Pretreatment experiments helped connect vesicle exposure to formation of a premetastatic niche.^[ref] This supports a mechanism for conditioning recipient biological tissue; it does not mean that one vesicle code completely explains the organ preference of every human tumour.

Reprogramming also includes metabolic cooperation. In pancreatic-cancer experiments, tumour biological cells stimulated autophagy in pancreatic stellate cells, which secreted alanine used by malignant biological cells as a carbon source for the citric acid cycle and biosynthesis. Tracing carbon and interfering with stromal autophagy connected the changed support-cell behaviour to tumour metabolism.^[ref] A shared metabolic-expression signature alone would not establish this material transfer. More generally, to establish a specific transfer, trace labelled substrates into recipient metabolites and biomass, distinguish exchange from independent use of the same nutrient, and block the proposed transport step with rescue by the downstream product. The tumour's advantage should be measured as survival, expansion or invasion under defined conditions.

A general causal design would compare tumour-conditioned and control-conditioned media on purified recipient biological cells, with matched biological cell numbers and viability, then wash and retest recipients to distinguish a persistent state from residual secreted factors. Ligand deletion in tumour biological cells, receptor deletion in recipients and recipient-specific rescue identify directionality. Add-back experiments, direct-contact versus barrier cultures and spatial lineage labels distinguish soluble signals, matrix effects and replacement by contaminating malignant biological cells. In vivo, use cell-type-specific interventions and immune-competent models where immune suppression is the proposed mechanism; a lymphocyte-deficient xenograft cannot establish the full immune interaction.

Importantly, supporting biological cells can also restrain disease. Depletion of alpha-smooth-muscle-actin-positive myofibroblasts in a pancreatic-cancer mouse model reduced fibrosis yet accelerated aggressive disease and immune suppression. The result shows that removing a conspicuous stromal component can eliminate protective functions as well as supportive ones.^[ref] The tumour's advantage emerges from particular reciprocal interactions, so the relevant question is which cell state and function are altered, rather than whether all surrounding normal biological cells are uniformly harmful.

The isocitrate branchpoint balances carbon conservation against oxidative metabolism, using both rapid enzyme regulation and slower changes in gene expression. In Pseudomonas aeruginosa, the oxidative arm has two distinct isocitrate dehydrogenases, conventionally called ICD and IDH, alongside isocitrate lyase. Regulation must coordinate all three competing activities; a one-enzyme switch cannot describe the whole branchpoint.

The carbon logic comes first. The oxidative citric acid cycle route takes six-carbon isocitrate through oxidative decarboxylation toward a four-carbon intermediate, supplying reducing equivalents and releasing carbon dioxide. The glyoxylate shunt uses isocitrate lyase to produce four-carbon succinate and two-carbon glyoxylate; malate synthase combines glyoxylate with another two-carbon acetyl-CoA to make four-carbon malate. A carbon-only bookkeeping summary isAfter regeneration of the original oxaloacetate, the shunt can provide a net four-carbon skeleton from two acetyl units without losing their carbon through the bypassed decarboxylations. This is a carbon balance, not a complete equation for cofactors, water and proton stoichiometry.

Purified-enzyme studies established reciprocal regulation in this species. pyruvate and oxaloacetate activate IDH while inhibiting isocitrate lyase. ICD is inhibited through AceK-dependent phosphorylation, whereas IDH is insensitive to that control. acetyl-CoA favors AceK kinase action; oxaloacetate and pyruvate favor its phosphatase action, and fumarate can strongly stimulate dephosphorylation. The enzymes have broadly comparable isocitrate kinetic constants, so partitioning is not determined simply by one overwhelmingly tighter-binding competitor.^[ref] Thus precursor abundance favors the oxidative route, while precursor shortage and acetyl-unit availability favor conservation through the shunt. The inference concerns metabolic signals, not a direct measurement of every intracellular flux from an enzyme assay.

Why is that feedback appropriate? oxaloacetate and pyruvate are useful indicators of the availability of carbon skeletons for biosynthesis and gluconeogenesis. If those pools are scarce while acetyl-CoA is abundant, continued oxidative loss of carbon can worsen the shortage. Favoring isocitrate lyase conserves substrate for replenishment. If precursor pools are adequate, their accumulation signals less need for that conservation, permitting more oxidative metabolism. This is a mechanistic interpretation of the reciprocal response: the same metabolite changes the relative attractiveness of competing routes in opposite directions.

Covalent and allosteric regulation solve related problems. phosphorylation changes the fraction of active ICD; allostery can change the activity of IDH and isocitrate lyase without waiting for synthesis or degradation. Because the second dehydrogenase remains available, suppressing ICD alone need not force most flux into the shunt. Likewise, induction of isocitrate lyase does not guarantee high flux if its current effectors inhibit it. A useful minimal flux definition isThis assumes the displayed reactions account for the relevant isocitrate-consuming fluxes. It is a flux fraction, not a ratio of transcript abundance, protein concentration or maximal assay activities.

For example, illustrative fluxes $v_{\mathrm{ICL}}=2$, $v_{\mathrm{ICD}}=3$ and $v_{\mathrm{IDH}}=5$ give $f_{\mathrm{shunt}}=0.20$. Inactivating four fifths of ICD while holding the other two rates fixed gives $2/(2+0.6+5)\simeq 0.263$, far from complete redirection. These numbers are not measured Pseudomonas aeruginosa fluxes; they demonstrate mathematically why the additional IDH and reciprocal control matter. In a real cell, isocitrate and effectors would also change, so fixed-rate reasoning is only a diagnostic toy calculation.

Transcription changes the available capacities over longer times. The genes aceA and glcB encode isocitrate lyase and malate synthase. Promoter reporters, DNA-affinity capture and genetic perturbation implicated RccR in carbon-source-dependent repression of the shunt machinery.^[ref] A later study directly identified KDPG as an RccR ligand and linked RccR-dependent control of central carbon genes to aminoglycoside tolerance.^[ref] A metabolite-sensing transcription factor can therefore adjust enzyme supply according to carbon metabolism, while the already present enzymes remain subject to rapid regulation. Reporter expression must be normalized to biomass and growth state; increased luminescence does not directly measure flux.

The branchpoint is important during growth on acetate ion or fatty acids, which supply acetyl units without automatically replacing the four-carbon precursors withdrawn for biomass. The shunt enables net assimilation into gluconeogenic material. However, carbon conservation has a cost: bypassing oxidative steps changes the yield and distribution of reducing equivalents and metabolites such as alpha-ketoglutarate. An exclusive shunt would not meet every requirement of the cell. Flexible partitioning allows the bacterium to exploit changing nutrient mixtures and maintain biosynthetic and energetic demands together.

This flexibility can also influence infection-associated physiology. Changes in oxidative metabolism can alter respiration, proton-motive force and the physiological response to some antibiotics. A survival phenotype is not equivalent to a higher resistance-conferring target-mutation frequency, and an enzyme essential in one carbon source need not be essential in every infection niche. Compare carbon-defined cultures, measure growth and respiration, and test whether the same metabolic perturbation changes both flux and antibiotic killing. The RccR evidence supports a connection to tolerance in the tested conditions rather than a universal therapeutic prediction.

A rigorous test combines carbon-13 metabolic flux analysis, intracellular metabolite measurements, enzyme phosphorylation state and gene-expression measurements. Use individual and combined dehydrogenase perturbations, isocitrate-lyase controls and genetic rescue. Confirm that the flux model can distinguish the oxidative route from the shunt and account for other anaplerotic reactions. The branchpoint is a regulated allocation decision: allostery, ICD phosphorylation and metabolite-responsive transcription cooperate to conserve carbon when precursors are limiting and support oxidative metabolism when their supply permits it.

Intracellular bacteria face a protected but highly controlled habitat: they must obtain host resources, avoid destruction, coordinate replication and reach the next host cell or host generation. Dependence evolves when access to that habitat is combined with loss or specialization of functions needed outside it. The selective pressures differ sharply between a pathogen spreading among hosts and a vertically inherited mutualist.

A first pressure is acquisition of a suitable intracellular niche. A bacterium entering by an uptake pathway may be delivered toward an acidified, degradative compartment. Chlamydia trachomatis instead replicates in an chlamydial inclusion whose interactions with host trafficking are modified by bacterial effectors. The niche supplies access to host-derived materials while keeping the replicating population spatially organized. Rickettsia prowazekii, in contrast, occupies the host cytoplasm after escape from an entry compartment. These are different solutions; it would be misleading to describe all intracellular bacteria as surviving by blocking lysosome fusion inside one generic vacuole.

The ability to manipulate trafficking and obtain metabolites becomes valuable. The Chlamydia trachomatis genome revealed a compact but specialized repertoire that includes transport and secretion-related functions, consistent with extensive host dependence.^[ref] genome annotation provides hypotheses about substrate use, not proof of actual import or enzyme activity. Test a candidate transporter's contribution using substrate uptake and intracellular growth, with genetic rescue and host-cell viability controls. A reduction in bacterial DNA can result from fewer entering bacteria, slower division or increased killing, so these stages should be measured separately.

Resource availability is selective rather than unlimited. A host cytoplasm may contain nutrients that are inaccessible across an chlamydial inclusion membrane, and an activated host can restrict metals or amino acids. Dependence on host supply favors uptake systems and scavenging, but makes the bacterium vulnerable to host nutrient restriction. The Rickettsia prowazekii genome showed extensive biosynthetic losses while retaining components of the citric acid cycle and respiration.^[ref] Thus an intracellular lifestyle does not mean universal loss of energy metabolism or reliance on one identical ATP-acquisition strategy. Imported metabolites and bacterial energy production can coexist.

Another pressure is coordination of the infectious and replicative phases. Chlamydia alternates between an elementary body, adapted for transmission and entry, and a reticulate body, adapted for growth inside the host. A durable infectious form can spend time outside a cell even when productive replication requires intracellular conditions. Developmental regulation therefore solves the conflict between surviving transfer and exploiting a nutrient-rich intracellular niche. Measure infectious progeny as well as genome copies: replication without successful differentiation need not yield transmission to another host cell.

Host defense creates additional pressures. Recognition of bacterial components can trigger inflammatory signaling, antimicrobial responses or death of the host cell before bacterial replication is complete. Pathogens can alter exposure, modify host signaling or delay destructive responses; the useful strategy depends on the niche and infection stage. Host-cell death may be harmful early yet assist release later, so “preventing apoptosis” cannot be treated as a universal permanent objective. To assign a bacterial effector's role, compare entry, replication, host response and release with an otherwise matched mutant, then restore the normal gene. Host toxicity caused by overexpressing an isolated effector is insufficient evidence for its physiological function during infection.

Some cytosolic species use the host cytoskeleton for movement and spread. Biochemical work on Rickettsia parkeri Sca2 demonstrated a formin-like actin assembly activity that helps explain the unbranched actin tails associated with spotted-fever rickettsiae.^[ref] Such movement can improve access to neighboring cells and reduce extracellular exposure. The result should not be generalized to every rickettsial species; different lineages have different motility repertoires. Inhibition of host actin also affects many host processes, so a bacterial separation-of-function mutant is more informative than a broad actin poison alone.

Long-term intracellular residence can produce genome reduction. Functions redundantly supplied by the host may become less strongly selected, permitting loss. Restricted transmission, small effective population size and limited recombination can also allow mildly deleterious changes to accumulate through genetic drift. Not every lost gene should be narrated as an adaptive improvement in efficiency. Compare closely related lineages, pseudogenes and host dependence; distinguish a dispensable ancestral pathway from a costly defect tolerated because the population cannot efficiently remove it.

Buchnera aphidicola illustrates a different outcome from pathogenic manipulation. It lives in aphid bacteriocytes and contributes to nutritional complementation in a host feeding on a restricted diet. genome sequencing showed strong reduction together with retention of substantial amino-acid biosynthetic capacity relevant to the association.^[ref] A vertically transmitted symbiont depends on host reproduction, which can favor cooperation and reliable transmission rather than maximal short-term host damage. Host and symbiont exchange still creates conflicts over resource allocation; stable association does not mean every trait benefits both partners equally.

Intracellular dependence should be tested operationally. Specialized host-cell-free culture allowed Coxiella burnetii, previously treated as obligatorily intracellular in culture, to grow under defined environmental and nutritional conditions.^[ref] It remains a highly specialized intracellular organism in its normal infection setting, but this experiment shows why failure in a standard laboratory medium is not proof that a living host is chemically indispensable. The main examples above concern established intracellular dependencies; Coxiella is a useful boundary case, not evidence that all such bacteria can be grown axenically.

Successful adaptation combines niche access, selective resource acquisition, control of host interactions and a transmission strategy. Over evolutionary time, those specializations can become irreversible dependencies through gene loss and population constraints, while the particular balance between host damage and cooperation follows the bacterium's route to the next generation.

The pyruvate dehydrogenase complex converts pyruvate into acetyl-CoA, releasing carbon dioxide and reducing NAD+ to NADH. Several catalytic components and enzyme cofactors couple decarboxylation, group transfer and oxidation within one assembly. It links glycolysis to the citric acid cycle, so control of the complex regulates the entry of carbohydrate-derived carbon into oxidative metabolism. A shared reaction intermediate can be passed between component active sites rather than diffusing freely through the cell. ^[ref]

Glycolysis converts glucose into two pyruvate molecules, with a net two ATP and reduced NADH; it does not directly consume molecular oxygen. Pyruvate processing and the citric acid cycle, also called the TCA cycle, release carbon dioxide and supply reduced carriers. Thus releasing carbon dioxide and consuming molecular oxygen occur at different stages.^[ref]

An electron transport chain reoxidizes carriers such as NADH. Coupling some of its redox steps to proton transport establishes an electrochemical gradient; ATP synthase can use that gradient to form ATP from adenosine diphosphate and inorganic phosphate. This is oxidative phosphorylation. A separate route, substrate-level phosphorylation, transfers a phosphate group from a reacting substrate to adenosine diphosphate. In typical eukaryotic biological cells, the respiratory chain occupies the inner membrane of a mitochondrion.^[ref]

The useful achievement is controlled transfer: fuel oxidation can replenish an ATP supply that supports active transport and synthesis. ATP is a reusable chemical carrier, not newly created energy; ATP hydrolysis and the coupled cellular process have their own net free energy balance. Some fuel energy is dissipated as heat.^[ref]

There is no universal yield of $36$ or $38$ ATP per glucose. Actual ATP recovery depends on carrier transfer routes, coupling and diversion of intermediates to other metabolism. In particular, an oxygen uptake rate cannot be converted into an ATP production rate by assuming one fixed multiplier.^[ref]

Succinate is the dianion of succinic acid, a four-carbon dicarboxylic acid with structure ${}^{-}\mathrm{OOC}-\mathrm{C}{\mathrm{H}}_2-\mathrm{C}{\mathrm{H}}_2-\mathrm{CO}{\mathrm{O}}^{-}$. It is an intermediate of the citric acid cycle.

Succinate dehydrogenase oxidizes succinate to fumarate, creating a carbon-carbon double bond while passing reducing equivalents into the respiratory machinery. This connects carbon-skeleton chemistry with electron transfer.